Browse Drug Recalls
14,380 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 14,380 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 14,380 FDA drug recalls, Class II.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Oct 7, 2022 | CYCLOSPORIN 0.07% OPTH 0.07% Solution in 10 mL bottles, Rx only, Vital Care C... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | LIDOCAINE/PHENYLEPHRINE PF SYR 1%/1.5% Solution, 3 mL syringes, Rx only, Vita... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | MITOMYCIN INJECTION 0.375 mg/mL SYR, 0.375 mg/mL solution, 1 mL syringe, Rx o... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | MEDROXYPROGESTERONE ACETATE 300 MG/ML Suspension, 10 mL vial, Rx only, Vital ... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | MOXIFLOXACIN PRESERVATIVE FREE SYR, 0.15 mg/0.1 mL, Sterile Solution, 1 mL sy... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | TALC, STERILE POWDER, 5 GM vial, Rx only, Vital Care Compounder, 115 S. 40th ... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PAPAVERINE HCL STOCK SOLUTION 30MG/ML SOLUTION, 10 mL vial, Rx only, Vital Ca... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | GLYCERIN OPHTHALMIC DROPS 98.5% Solution, 10 mL droptainer, Rx only, Vital Ca... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | VORICONAZOLE OPTH SOLUTION 2% STERILE SOLN, 10 ML droptainer, Rx only, Vital ... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150/5/50MCG / VIAL SOLUTION, 10 mL ... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 75MG/2.5MG/50MCG/ BOTTLE SOLUTI... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | SERUM TEARS IN NSAL 20% OPTH SOLUTION, 3 mL droptainers, Rx only, Vital Care ... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PAPAVERINE / PHENTOLAMINE INJECTION 150MG / 5MG / VIAL SOLUTION, 10 mL vials,... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | ACETYLCYSTEINE OPTH 10% Solution, 15 mL droptainers, Rx only, Vital Care Comp... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PHENTOLAMINE 10MG/ML INJECTION, 10MG/ML SOLUTION, 10 mL vial, Rx only, Vital ... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | METHYLCOBALAMIN PF 1 ML Injection Solution 5,000 MCG/ML Solution, 1 mL vials,... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe, Rx only, Vita... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PRED ACETATE / GATIFLOXACIN 1% / 0.5% SUSP, 10 mL droptainers, Rx only, Vital... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150MG/5MG/10MCG/VIAL SOLUTION, 5 ML... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | LAURETH-9 INJ 2% Solution, 30 ML vial, Rx only, Vital Care Compounder, 115 S.... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 7, 2022 | PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 150MG/10MG/100MCG/ BOTTLE SOLUT... | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a man... | Class II | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Oct 6, 2022 | Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Pat... | Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit fo... | Class II | Golden State Medical Supply Inc. |
| Oct 6, 2022 | SIREtizer Hand Sanitizer (Ethyl Alcohol) 80%, packaged in a) 3.38 oz (100 mL)... | CGMP Deviations and Superpotent Drug: Levels of acetal and acetaldehyde above allowable limits. A... | Class II | Southwest Iowa Renewable Energy LLC |
| Oct 6, 2022 | Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323... | Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit fo... | Class II | Golden State Medical Supply Inc. |
| Oct 5, 2022 | Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottle... | CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit. | Class II | Aurobindo Pharma USA Inc. |
| Sep 30, 2022 | Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured ... | Out of specification for related substances (impurities). | Class II | Ingenus Pharmaceuticals Llc |
| Sep 30, 2022 | Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled... | Subpotent Drug: Out of specification for assay | Class II | AuroMedics Pharma LLC |
| Sep 30, 2022 | Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged ... | cGMP Deviations: Out of specification for assay of one of the preservative ingredients. | Class II | VistaPharm, Inc. |
| Sep 29, 2022 | Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose... | Lack of Assurance of Sterility: environmental monitoring failure. | Class II | CIPLA |
| Sep 27, 2022 | Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose via... | Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial. | Class II | Pfizer Inc. |
| Sep 26, 2022 | Acyclovir Sodium Injection, 500mg/10mL (50mg/mL), 10 mL Single Dose Vial, Rx ... | Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate fl... | Class II | AuroMedics Pharma LLC |
| Sep 21, 2022 | Rifampin Capsules, USP, 300 mg, a) 30-count bottle (NDC 61748-018-30), b) 60-... | Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit fo... | Class II | Akorn, Inc. |
| Sep 21, 2022 | Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Ako... | Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit fo... | Class II | Akorn, Inc. |
| Sep 21, 2022 | Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 ... | Presence of Particulate Matter: A complaint was received for the presence of a single strand of h... | Class II | Viatris Inc |
| Sep 16, 2022 | Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx... | CGMP deviations: Out of specification results obtained during routine stability testing for ethan... | Class II | Novartis Pharmaceuticals Corporation |
| Sep 15, 2022 | Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, ... | Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet. | Class II | RemedyRepack Inc. |
| Sep 15, 2022 | Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 ... | Lack of Assurance of Sterility | Class II | CIPLA |
| Sep 14, 2022 | Sanitizing Hand Spray 80% (alcohol 80% v/v) Packaged in 2 FL OZ (60 mL) bottl... | GMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification... | Class II | Salon Technologies International Inc |
| Sep 13, 2022 | Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for:... | Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet. | Class II | Lupin Pharmaceuticals Inc. |
| Sep 12, 2022 | Triamcinolone Acetonide cream, 0.1%, 80 g tube, Rx only, Packaged and Distrib... | CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of ef... | Class II | Direct Rx |
| Sep 9, 2022 | Skincell Mole & Skin Corrector Serum, 1 fl. oz./30 mL jars, Distributed By: ... | Marketed Without An Approved NDA/ANDA; Unapproved new drug | Class II | Justified Laboratories |
| Sep 9, 2022 | Skincell Mole & Skin Corrector Serum, 1 fl. oz./30 mL jars, Distributed By: ... | Marketed Without An Approved NDA/ANDA; Unapproved new drug | Class II | Justified Laboratories |
| Sep 1, 2022 | Synergy Hand Sanitizer, Non-Sterile Solution to help reduce bacteria that can... | CGMP Deviations: FDA analysis found product to contain acetaldehyde impurity and the Sum of All I... | Class II | SUPERIOR GLOVE WORKS, LTD. |
| Aug 31, 2022 | Sodium Chloride Ophthalmic Ointment USP, 5%, Sterile, Net Wt 3.5 g (1/8 oz) t... | cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scop... | Class II | Akorn, Inc. |
| Aug 31, 2022 | Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufact... | cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scop... | Class II | Akorn, Inc. |
| Aug 29, 2022 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfat... | Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually... | Class II | Teva Pharmaceuticals USA Inc |
| Aug 26, 2022 | TEST CYP (Grapeseed) 200 MG/ML Injectable, 10 ML vial, Rx only, Carolina Infu... | Lack of Assurance of Sterility | Class II | Carolina Infusion |
| Aug 26, 2022 | TEST CYP/PROP (50:50) 100 MG/100 MG/ML Injectable, 12.6 ML vial, Rx only, Car... | Lack of Assurance of Sterility | Class II | Carolina Infusion |
| Aug 26, 2022 | MIC/B12/L-Carn (HD) 35/35/35/1/35 MG/ML Injectable, 10 ML vial, Rx only, Caro... | Lack of Assurance of Sterility | Class II | Carolina Infusion |
| Aug 26, 2022 | TRI-MIX 50/2.5/25 Injectable, 2 ML vial, Rx only, Carolina Infusion LLC, 95 B... | Lack of Assurance of Sterility | Class II | Carolina Infusion |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.